NANOCOMPOSIX, INC. — Department of Defense SBIR Phase I: DHP15-006
NANOCOMPOSIX, INC. — SBIR Phase I award from Department of Defense.
- Amount
- $150,000
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase I
- Topic
- DHP15-006
- Solicitation
- 2015.1
- NAICS
- —
- Place of performance
- CA
- Period
- 2015-09-29 → 2016-04-26
Description
Lyme disease is the most common tick-borne disease in North America and one of the fast-growing infectious diseases in the United States. An inexpensive, portable and accurate diagnostic device for the detection of Borrelia bacteria in the deer tick will be developed. The diagnostic device will consist of an efficient extractor for disrupting the hard exoskeleton on the tick, an ultra-sensitive lateral flow based detection assay and a cell phone reader attachment for quantifying and geotagging the test strip results. The detection kit will have a small form factor, will be simple to use and will require minimal power.